Doctors Without Borders/Médecins Sans Frontières (MSF) frequently publishes updates, press releases, and other forms of communication about its work in more than 60 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

September 21, 2016

"Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the United Nations’s (UN) Political Declaration Antimicrobial Resistance, which recognizes the need to address – at the highest political levels – the complex issue of drug-resistant infections, which affect people in every part of the world. Now, governments have the responsibility to turn these words into action and fully implement nationally-tailored plans and global commitments to combat antimicrobial resistance (AMR).

September 20, 2016

MSF calls on Pfizer to match GSK’s move and offer the humanitarian community the lowest global price for this lifesaving vaccine

September 19, 2016

“After years of fighting for children caught in crises and desperately in need of the pneumonia vaccine, Doctors Without Borders/Médecins Sans Frontières is relieved to see that GlaxoSmithKline (GSK) finally plans to reduce its vaccine price for humanitarian organizations. GSK is leading the way in this commitment to children who are experiencing the most horrific of circumstances, while Pfizer continues to hide behind excuses and offer only piecemeal approaches to the humanitarian community.

September 16, 2016

"The sustainable development goals (SDGs) adopted with much fanfare just a year ago seek to end HIV, tuberculosis, and malaria by 2030. The replenishment of the Global Fund is the first concrete action taken by the international community since the adoption of these goals, and therefore a first test of the world leaders' will to make them a reality. Failure to reach the relatively modest Global Fund's replenishment target would be a clear message that the SDGs were but empty promises to the millions who, every year, continue to suffer and die from HIV, tuberculosis, and malaria."

September 14, 2016

On September 14, The United Nations Secretary-General’s High-Level Panel (UNHLP) on Access to Medicines will publish a landmark report on promoting innovation for and access to lifesaving medical tools.

September 13, 2016

Click Here to Download the Report

Every day, Doctors Without Borders/Médecins Sans Frontières (MSF) staff confront significant gaps in the availability of medical tools to address the health needs of the people we aim to care for in crisis-affected communities in more than 60 countries. These gaps—which have persisted for as long as MSF has been in operation—contribute to preventable deaths and exacerbate ongoing humanitarian and medical crises.

September 02, 2016

As the United States and other member countries of the G20 meet in Hangzhou, China, September 4-5, Doctors Without Borders/Médecins Sans Frontières (MSF) is urging them to address the failures of medical research and development (R&D) to deliver medicines, vaccines and diagnostics that match the health needs of people around the world instead of only focusing on the most lucrative products.

June 06, 2016

Rohit Malpani, director of policy and analysis at Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign, delivered the following remarks at Meeting the Challenge of Antimicrobial Resistance, an event hosted by the United Nations’ Every Woman Every Child movement.

June 02, 2016

India must resist pressure from US lawmakers and pharmaceutical industry groups to block access to key medicines for millions of people worldwide

May 27, 2016

NEW YORK/ISE-SHIMA, JAPAN, MAY 27, 2016—While G7 leaders acknowledged during their summit this week that the current system of research and development is failing to deliver innovation and affordable access to medicines and vaccines for people around the world, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is disappointed that the solutions proposed by the G7 will not address these failures head-on.

MSF issued the following statement from Jeremie Bodin, general director of MSF Japan:

Pages